(Q77933882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Ángel-Luis García-Otín

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

F Civeira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A Cenarro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Ferrando

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Puzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P Mozas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Pocoví

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

156-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Apolipoprotein E polymorphism in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136 → Ser) variant in multigenerational pedigree studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Apo E variants in patients with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Long-term effects of simvastatin in familial dysbetalipoproteinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

The two-period cross-over clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Effect of fenofibrate treatment on type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Lipoproteins in familial dysbetalipoproteinemia. Variation of serum cholesterol level associated with VLDL concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970262-0

10.1016/S0002-8703(99)70262-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385780%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference